For research use only. Not for therapeutic Use.
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer’s disease research[1].
Catalog Number | I043776 |
CAS Number | 1043556-46-2 |
Purity | ≥95% |
Reference | [1]. Bernd Bohrmann, et al. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β. J Alzheimers Dis. 2012;28(1):49-69. |